The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khelminskaya N.M.

N.I. Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow, Russia, 117997

Magomedov M.M.

Kafedra gospital'noĭ khirurgii Dagestanskoĭ gosudarstvennoĭ meditsinskoĭ akademii, Makhachkala

Goncharova A.V.

Petrovsky National Research Centre of Surgery, 119991, Abrikosovsky, 2, Moscow, Russia

Kravets V.I.

FSBEI HE «RNIU them N.I. Pirogov, Ministry of Health of the Russian Federation, Department of Maxillofacial Surgery and Dentistry, Faculty of Dentistry, Moscow, Russia, 117997

Krasnov N.M.

FSBEI HE «RNIU them N.I. Pirogov, Ministry of Health of the Russian Federation, Department of Maxillofacial Surgery and Dentistry, Faculty of Dentistry, Moscow, Russia, 117997

Bagdasaryan A.A.

FSBEI HE «RNIU them N.I. Pirogov, Ministry of Health of the Russian Federation, Department of Maxillofacial Surgery and Dentistry, Faculty of Dentistry, Moscow, Russia, 117997

Experience of the interdisciplinary approach to diagnostics and treatment of patients with bisphosphonate osteonecrosis of the upper jaw

Authors:

Khelminskaya N.M., Magomedov M.M., Goncharova A.V., Kravets V.I., Krasnov N.M., Bagdasaryan A.A.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2019;84(5): 44‑47

Read: 2457 times


To cite this article:

Khelminskaya NM, Magomedov MM, Goncharova AV, Kravets VI, Krasnov NM, Bagdasaryan AA. Experience of the interdisciplinary approach to diagnostics and treatment of patients with bisphosphonate osteonecrosis of the upper jaw. Russian Bulletin of Otorhinolaryngology. 2019;84(5):44‑47. (In Russ.)
https://doi.org/10.17116/otorino20198405144

Recommended articles:

References:

  1. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2017 g. Ed. Kaprina A.D., Starinsky V.V., Petrova G.V. M.: MNIOI im. P.A. Gertsena filial FGBU «NMITs radiologii» Minzdrava Rossii; 2018. (In Russ.)
  2. Oxenoyt GK, Nikitina SYu i dr. Zdravookhranenie v Rossii. 2017: Stat.sb./Rosstat. M. 2017;170. (In Russ.)
  3. Perevodchikova NI. Bisphosphonates and their role in the treatment of patients with bone metastases. Russkii Meditsinskii Zhurnal. Accessed 11.07.07 (In Russ.). https://www.rmj.ru/articles/onkologiya/Bisfosfonaty_i_ih_roly_v_lechenii_bolynyh_s_kostnymi_metastazami/#ixzz5i9PVIjXv
  4. Nyushko KM, Kalpinsky AS, Kaprin AD. Prevention of the development of complications in prostate cancer patients with bone metastases. Issledovaniya i Praktika v Meditsine. 2015;2(3):76-81. (In Russ.)
  5. Hortobagyi GN. Modern management of bone metastases. Abstract book 18 International Congress on Anti Cancer Treatment. 2007;168-173.
  6. Berenson JR. Recommendations for Zoledronic Acid Treatment of Patients with Bone Metastases. The Oncologist. 2005;10:52-56.
  7. Santhosh Kumar MP, Sagunthala Ettikan. Bisphosphonate-Related Osteonecrosis of the Jaws. J Pharm Sci & Res. 2016;8(4):198-203.
  8. Spevak EM, Tsymbal AM. Bisphosphonate osteonecrosis of the jaws: current state of the problem. Kazanskii Meditsinskii Zhurnal. 2017;98(1):91-95. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.